Gut Microbiome in Inflammatory Bowel Disease
Recruiting
Observational Study
Inflammatory Bowel Diseases
Ulcerative Colitis
Crohn Disease
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,500 (estimated)
- Sponsor
- Kyunghee University Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Inflammatory bowel disease (IBD) is a chronic inflammatory condition for gastrointestinal tract. There have been numerous studies to reveal dysbiosis of fecal/mucosal microbiome composition in IBD patients but actual trend of dysbiosis is strikingly different among patient's ethnicity.
In this background, the investigators have composed a prospective cohort of Korean IBD patients in a large acade…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with established diagnosis of inflammatory bowel disease, including ulcerative colitis and Crohn disease
Exclusion Criteria:
* Person with history of using antibiotics or probiotics within previous 2 weeks.
Contacts